Long-Term, Open Label Extension Study of Pemziviptadil (PB1046) in PAH Subjects Following Completion of Study PB1046-PT-CL-0004

Clinical trial NCT03795428 · TERMINATED

Trial details

NCT number: NCT03795428
Sponsor: PhaseBio Pharmaceuticals Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2019-04-10
Primary completion: 2022-01-11
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.